A microarray based expression profiling of paclitaxel and vincristine resistant MCF-7 cells.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Journal of Pharmacology

• Publication date

  2011-04-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejphar.2011.02.001PMID 21320484
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug resistant breast cancer cells overexpress ETS1 gene.

  2010cited by this paper
• Development of radioresistance in drug resistant human MCF-7 breast cancer cells

  2009cited by this paper
• Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins

  2009cited by this paper
• Drug Resistant MCF-7 Cell Lines Also Developed Cross-Resistance to Structurally Unrelated Anticancer Agents

  2009cited by this paper
• Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.

  2008cited by this paper
• Taxanes, microtubules and chemoresistant breast cancer.

  2008cited by this paper
• Reversal of Multidrug Resistance by Synthetic and Natural Compounds in Drug-Resistant MCF-7 Cell Lines

  2008cited by this paper
• P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.

  2006cited by this paper
• Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.

  2006cited by this paper
• Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.

  2006cited by this paper
• Mechanism of action of glutathione-dependent enzymes.

  2006cited by this paper
• Tumor microenvironment and drug resistance in hematologic malignancies.

  2006cited by this paper
• BRCA1--a good predictive marker of drug sensitivity in breast cancer treatment?

  2006cited by this paper
• Expression Profiling of ABC Transporters in a Drug-Resistant Breast Cancer Cell Line Using AmpArray

  2005cited by this paper
• Understanding microtubule dynamics for improved cancer therapy

  2005cited by this paper
• Programmed Cell Death 6 (PDCD6) Protein Interacts with Death-Associated Protein Kinase 1 (DAPk1): Additive Effect on Apoptosis via Caspase-3 Dependent Pathway

  2005cited by this paper
• Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer.

  2005cited by this paper
• The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling.

  2005cited by this paper
• Do beta-tubulin mutations have a role in resistance to chemotherapy?

  2004cited by this paper
• BRCA1 Interacts with and Is Required for Paclitaxel-Induced Activation of Mitogen-Activated Protein Kinase Kinase Kinase 3

  2004cited by this paper
• Microtubules as a target for anticancer drugs

  2004cited by this paper
• Do β-tubulin mutations have a role in resistance to chemotherapy?

  2004cited by this paper
• The immunopharmacology of paclitaxel (Taxol), docetaxel (Taxotere), and related agents.

  2003cited by this paper
• Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death

  2003cited by this paper
• Expression of class III beta-tubulin reduces microtubule assembly and confers resistance to paclitaxel.

  2003cited by this paper
• Anticancer therapy targeting the apoptotic pathway.

  2003cited by this paper
• Mutational analysis of the class I beta-tubulin gene in human breast cancer.

  2002cited by this paper
• Cancer susceptibility and the functions of BRCA1 and BRCA2.

  2002cited by this paper
• Review Cancer Susceptibility and the Functions of BRCA1 and BRCA2

  2002cited by this paper
• Mutational analysis of the class I β‐tubulin gene in human breast cancer

  2002cited by this paper
• Microtubule alterations and resistance to tubulin-binding agents (review).

  2002cited by this paper
• Role of AP-1 and HIF-1 Transcription Factors in TGF-β Activation of VEGF Expression

  2001cited by this paper
• BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents

  2001cited by this paper
• TAXOL INDUCED BCL‐2 PROTEIN PHOSPHORYLATION IN HUMAN HEPATOCELLULAR CARCINOMA QGY‐7703 CELL LINE

  2001cited by this paper
• Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer

  2001cited by this paper
• Altered cell cycle response of drug-resistant lung carcinoma cells to doxorubicin.

  2000cited by this paper
• Drug Resistance in Breast Cancer

  1999cited by this paper
• Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype.

  1999cited by this paper
• Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.

  1999cited by this paper
• The apoptosome: heart and soul of the cell death machine.

  1999cited by this paper
• The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells

  1998cited by this paper
• Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis*

  1998cited by this paper
• Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.

  1998cited by this paper
• Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization*

  1997cited by this paper
• Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis

  1997cited by this paper
• Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine.

  1996cited by this paper
• MRP and MDR1 gene expression in primary breast carcinomas.

  1996cited by this paper
• Multidrug resistance associated with overexpression of MRP.

  1996cited by this paper
• Wild-type p53 negatively regulates the expression of a microtubule-associated protein.

  1996cited by this paper
• Multidrug resistance proteins and other drug transport-related resistance to natural product agents.

  1995cited by this paper
• Interleukin-6 in biology and medicine.

  1993cited by this paper
• Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma.

  1992cited by this paper
• Special article the glutathione S‐transferases: An update

  1989cited by this paper
• The glutathione S-transferases: an update.

  1989cited by this paper

• Adipose Stromal Cell Heterogeneity and Trafficking: Implications for Breast Cancer Metastasis and Obesity.

  2025cites this paper
• Vincristine in Cancer Therapy: Mechanisms, Efficacy, and Future Perspectives.

  2024cites this paper
• Proteomics-Based Discovery of First-in-Class Chemical Probes for Programmed Cell Death Protein 2 (PDCD2).

  2023cites this paper
• PLGA-Lipid Hybrid Nanoparticles for Overcoming Paclitaxel Tolerance in Anoikis-Resistant Lung Cancer Cells

  2022cites this paper
• Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs

  2022cites this paper
• The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer

  2022cites this paper
• Biomarkers to target and silence stemness of breast cancer stem cell model: silencing MDR1 by siRNA

  2022cites this paper
• Interplay Between Non-Coding RNAs and Programmed Cell Death Proteins

  2022cites this paper
• Investigating the Effects of DNA Demethylation in Chemotherapy Resistance by ChIP-on-Chip Method

  2020cites this paper
• Specific c ‐ Jun N ‐ Terminal Kinase Inhibitor , JNK ‐ IN ‐ 8 Suppresses Mesenchymal Profile of PTX ‐ Resistant MCF ‐ 7 Cells through Modulating PI 3 K / Akt , MAPK and Wnt Signaling

  2020cites this paper
• Specific c-Jun N-Terminal Kinase Inhibitor, JNK-IN-8 Suppresses Mesenchymal Profile of PTX-Resistant MCF-7 Cells through Modulating PI3K/Akt, MAPK and Wnt Signaling Pathways

  2020cites this paper
• Implications from a microarray analysis: Solute carrier proteins may be potential targets to combat stemness of breast cancer

  2020cites this paper
• 15‐LOX‐1 has diverse roles in the resensitization of resistant cancer cell lines to doxorubicin

  2020cites this paper
• PDCD2 sensitizes HepG2 cells to sorafenib by suppressing epithelial-mesenchymal transition

  2019cites this paper
• Determination of the target proteins in chemotherapy resistant breast cancer stem cell‐like cells by protein array

  2019cites this paper
• The Molecular Evolution and Functional Divergence of Lamprey Programmed Cell Death Genes

  2019cites this paper
• lncRNA profile study reveals the mRNAs and lncRNAs associated with docetaxel resistance in breast cancer cells

  2018cites this paper
• Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8

  2018cites this paper
• Dual function of programmed cell death 10 (PDCD10) in drug resistance.

  2018cites this paper
• Theoretical and experimental study of polycyclic aromatic compounds as β-tubulin inhibitors

  2017cites this paper
• Characterization of multidrug‑resistant osteosarcoma sublines and the molecular mechanisms of resistance.

  2016cites this paper
• Nanoparticle-based drug delivery in cancer: the role of cell membrane structures.

  2016cites this paper
• Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High‐Grade Differentiation of Xenografted Tumours in Nude Mice

  2016cites this paper
• Differentially expressed proteins in human MCF-7 breast cancer cells sensitive and resistant to paclitaxel.

  2015cites this paper
• Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways

  2015cites this paper
• The effects of telomere shortening on cancer cells: a network model of proteomic and microRNA analysis.

  2015cites this paper
• Differentially expressed proteins in human breast cancer cells sensitive and resistant to paclitaxel.

  2014cites this paper
• A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression.

  2014cites this paper
• Drug Resistance in Breast Cancer: Characterization of Rationally Designed Paclitaxel Analogs in Model Systems

  2013cites this paper
• Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-HER2/neu] in Combination with Griseofulvin against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3)

  2013cites this paper
• Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways

  2013cites this paper
• Exploring a natural MDR reversal agent: potential of medicinal food supplement Nerium oleander leaf distillate.

  2013cites this paper
• Determination of saikosaponin, phenolic and podophyllotoxin contents of five endemic Bupleurum root extracts and their effects on MCF-7 cells

  2012cites this paper
• Treatments of paclitaxel with poly(vinyl pyrrolidone) to improve drug release from poly(ɛ-caprolactone) matrix for film-based stent.

  2012cites this paper
• Modulation of MDR1 and MRP3 Gene Expression in Lung Cancer Cells after Paclitaxel and Carboplatin Exposure

  2012cites this paper
• Influence of Alternative Tubulin Inhibitors on the Potency of a Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate: Influence of incorporating an internal/integral disulfide bond structure and Alternative Tubulin/Microtubule Inhibitors on the Cytotoxic An

  2012cites this paper
• Evolutionary karyotypic theory of cancer versus conventional cancer gene mutation theory

  2012cites this paper